Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia
Authors:
- Yvan GuindonYGYvan Guindon
- Marvin M. GoldenbergMGMarvin M. Goldenberg
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (19) , 3201-3204
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacological modulation of eicosanoid levels and hyperalgesia in yeast-induced inflammationBiochemical Pharmacology, 1987
- Leukotriene B 4 Produces Hyperalgesia That Is Dependent on Polymorphonuclear LeukocytesScience, 1984
- Inflammatory characteristics of platelet activating factor (PAF-acether) in human skinBritish Journal of Dermatology, 1984
- Paf-acether: a mediator of inflammation and asthmaTrends in Pharmacological Sciences, 1984
- Neutrophil aggregating properties of PAF-acether and leukotriene B4International Journal of Immunopharmacology, 1983
- Nonimmunological Production pf Leukotrienes Induced by Platelet-Activating FactorScience, 1982
- Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanismImmunopharmacology, 1982
- Stimulation of human neutrophil degranulation with 1-0-octadecyl-2-0-acetyl-sn-glyceryl-3-phosphorylcholine: Modulation by inhibitors of arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1982
- Release of platelet‐activating factor (PAF‐acether) and leukotrienes C and D from inflammatory macrophagesEuropean Journal of Immunology, 1982
- Inhibition of rabbit PMN lipoxygenase activity by benoxaprofenJournal of Pharmacy and Pharmacology, 1979